Condition
Idiopathic Overactive Bladder
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (5)
P 4 (1)
Trial Status
Recruiting2
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07209397Not ApplicableRecruiting
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
NCT04444440Phase 4RecruitingPrimary
Antibiotic Prophylaxis for Bladder Botox
NCT05352945Not ApplicableTerminatedPrimary
Effectiveness of HYPNOsis Masks During Botulinum TOXin Injections in Idiopathic Overactive Bladder(HypnoTox)
NCT05387824Not ApplicableUnknownPrimary
Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder
NCT04389307Not ApplicableCompletedPrimary
Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder
NCT01783392Not ApplicableCompletedPrimary
Peripheral Electrical Stimulation for the Treatment of Overactive Bladder
Showing all 6 trials